You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《半日速報》恆指半日收報24,534點 升17點; 恆生科技指數半日收報5,434點 升15點 百濟神州升逾8% 百濟神州、翰森製藥、中國宏橋、德昌電機、康諾亞-B創新高
恆指半日收24,534點,升17點或0.1%。恆生科技指數報5,434點,升15點或0.3%。國指升4點或0.0%,報8,865點。 活躍重磅股表現: 美團(03690.HK) 收126.2元,上升1.7%; 小米集團(01810.HK) 收56.45元,下跌1.5%; 阿里巴巴(09988.HK) 收113.1元,下跌0.6%; 騰訊(00700.HK) 收516元,下跌0.1%; 異動恆指及國指成份股: 百濟神州(06160.HK) 收179.8元,上升8.5%,創新高; 吉利(00175.HK) 收18.92元,上升3.6%; 百度集團-SW(09888.HK) 收85.35元,下跌3.6%; 中生製藥(01177.HK) 收6.66元,上升3.4%; 農夫山泉(09633.HK) 收41.8元,上升3.3%; 藥明生物(02269.HK) 收28.1元,上升3.3%; 翰森製藥(03692.HK) 收34.1元,上升3.2%,創新高; 中國宏橋(01378.HK) 收18.78元,上升2.5%,創新高; 異動綜合中小型股: 中國軟件國際(00354.HK) 收5.87元,上升15.1%; 粉筆(02469.HK) 收3.42元,上升14.8%; 德昌電機(00179.HK) 收25.8元,上升13.7%,創新高; 樂普生物(02157.HK) 收5.79元,上升13.3%; 康諾亞-B(02162.HK) 收56.2元,上升12.4%,創新高; 康方生物(09926.HK) 收138.8元,上升10.2%,創新高; ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account